Home
About
Overview
Sharing Data
ORCID
Help
History (48)
Diet, Fat-Restricted
Serum
Recent advances in the rapidly evolving field of fibroblast growth factor 23 in chronic kidney disease.
Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma.
Malignant bowel obstruction due to uterine or ovarian cancer: Are there differences in outcome?
See All 48 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Malignant bowel obstruction due to uterine or ovarian cancer: Are there differences in outcome?
Malignant bowel obstruction due to uterine or ovarian cancer: Are there differences in outcome? Gynecol Oncol. 2019 07; 154(1):177-182.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Female
Humans
Intestinal Obstruction
Middle Aged
Neoplasm Recurrence, Local
Ovarian Neoplasms
Retrospective Studies
Treatment Outcome
Uterine Neoplasms
authors with profiles
Nita Lee
Seiko Diane Yamada